
Arthroplasty
Large-scale trial comparing topical and intravenous TXA efficacy in total knee arthroplasty
J Bone Joint Surg Am. 2018 Jun 20;100(12):1023-1029664 patients scheduled for total knee arthroplasty were randomized to either topical tranexamic acid or intravenous tranexamic acid. Patients were assessed for total blood loss, postoperative blood loss, and the incidence of transfusion. Results demonstrated that despite the statistically significantly lower total and postoperative blood loss in the intravenous group, there was no significant difference in the incidence of postoperative transfusion between groups.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.